VINCERX PHARMA INC

CUSIP: 92731L106 Class: COM NEW

SAGE RHINO CAPITAL LLC's Holding History (CIK: 0001771605)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024
Shares 1,703,413 Value ($000) $448 Avg Close — Range —
Q3 2024
Shares 1,703,413 Value ($000) $1,220 Avg Close — Range —
Q2 2024
Shares 1,703,413 Value ($000) $1,380 Avg Close — Range —
Q1 2024
Shares 1,703,413 Value ($000) $8,619 Avg Close — Range —
Q4 2023
Shares 1,703,413 Value ($000) $2,010 Avg Close — Range —
Q3 2023
Shares 1,703,413 Value ($000) $1,720 Avg Close — Range —
Q2 2023
Shares 1,686,937 Value ($000) $2,193 Avg Close — Range —
Q1 2023
Shares 1,686,937 Value ($000) $1,754 Avg Close — Range —
Q4 2022
Shares 1,686,937 Value ($000) $1,721 Avg Close — Range —
Q3 2022
Shares 1,658,199 Value ($000) $2,288 Avg Close — Range —
Q2 2022
Shares 1,658,199 Value ($000) $2,189 Avg Close — Range —
Q1 2022
Shares 1,618,199 Value ($000) $6,473 Avg Close — Range —
Q4 2021
Shares 1,618,199 Value ($000) $16,489 Avg Close — Range —
Q3 2021
Shares 1,618,199 Value ($000) $26,166 Avg Close — Range —
Q2 2021
Shares 1,618,199 Value ($000) $21,020 Avg Close — Range —
Q1 2021
Shares 1,618,199 Value ($000) $31,231 Avg Close — Range —